Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 91.5B | 57.7B | 46.0B | 42.4B |
Cost of revenue | 47.5B | 29.8B | 21.4B | 23.2B |
Gross profit | 44.0B | 27.9B | 24.6B | 19.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 8.2B | 4.5B | 4.1B | 3.1B |
Operating income | 26.8B | 15.6B | 12.9B | 8.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 58.6M | 13.2M | 13.2M | 11.8M |
Other income expense | — | — | — | — |
Pretax income | 28.7B | 17.4B | 14.5B | 10.4B |
Tax provision | 7.5B | 4.4B | 3.6B | 2.6B |
Net income | 21.3B | 13.1B | 10.9B | 7.9B |
Basic EPS | — | 1.8 | 1.5 | 1.1 |
Diluted EPS | — | 1.8 | 1.5 | 1.1 |
Basic average shares | — | 7.3B | 7.3B | 7.3B |
Diluted average shares | — | 7.3B | 7.3B | 7.3B |
EBITDA | 30.1B | 18.6B | 15.6B | 11.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | 200K | -6.5M | -3.3M | -2.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |